NEW YORK (GenomeWeb News) – Hologic reported after the close of the market Monday that its fourth-quarter 2012 revenues climbed 26 percent year over year with a large chunk of that increase due to Gen-Probe's sales contribution.

The Bedford, Mass.-based diagnostics, medical imaging, and surgical products firm reported total revenues of $588.5 million for the three months ended Sept. 29, up from $467.0 million for the fourth quarter of 2011. It beat the consensus Wall Street estimate of $581.6 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.

Aug
20
Sponsored by
Canon BioMedical

This webinar will provide an overview of recent advances in single-cell RNA sequencing from the perspectives of three research organizations.